Abstract: An exemplary system includes a memory storing instructions and one or more processors communicatively coupled to the memory and configured to execute the instructions to perform a process comprising: accessing fitting data representative of fitting parameters set by a fitting application to fit a hearing device to a user; determining user behavior data indicative of a hearing intention of the user in an auditory scene where the user is located; determining auditory scene data representative of information about the auditory scene; and implementing, based on the fitting data, the user behavior data, and the auditory scene data, a sound processing delay scheme for use by the hearing device.

Abstract: A method for determining social interaction of a user wearing a hearing device which comprises at least one microphone and at least one classifier. The method comprises: receiving an audio signal from the at least one microphone and/or a sensor signal from the at least one further sensor; identifying, by the at least one classifier, one or more predetermined user activity values by evaluating the audio signal from the at least one microphone and/or the sensor signal from the at least one further sensor; and calculating a user social interaction metric indicative of the social interaction of the user from the identified user activity values, wherein the user activity values are assigned to predefined social interaction levels, and wherein the user social interaction metric is a function of the user activity values weighted with their respective contribution to each of the social interaction levels.

Abstract: A method for determining social interaction of a user wearing a hearing device which comprises at least one microphone and at least one classifier. The method comprises: receiving an audio signal from the at least one microphone and/or a sensor signal from the at least one further sensor; identifying, by the at least one classifier, one or more predetermined user activity values by evaluating the audio signal from the at least one microphone and/or the sensor signal from the at least one further sensor; and calculating a user social interaction metric indicative of the social interaction of the user from the identified user activity values, wherein the user activity values are assigned to predefined social interaction levels, and wherein the user social interaction metric is a function of the user activity values weighted with their respective contribution to each of the social interaction levels.

Abstract: The disclosed technology generally relates to a hearing device configured to process a signal in a first path and a second path, where the first path and second path apply different digital signal processing operations to the signal. The hearing device is configured to determine a relatedness factor that compares the processed signals along the first and second path. Based on the relatedness factor, the hearing device can apply different gains to the signal in the first and second paths. The hearing device can output a combined signal based on the signals from the first and second paths. In some embodiments, the second path can be associated with receiving a signal from an external device.

Abstract: The disclosed technology generally relates to a hearing device configured to process a signal in a first path and a second path, where the first path and second path apply different digital signal processing operations to the signal. The hearing device is configured to determine a relatedness factor that compares the processed signals along the first and second path. Based on the relatedness factor, the hearing device can apply different gains to the signal in the first and second paths. The hearing device can output a combined signal based on the signals from the first and second paths. In some embodiments, the second path can be associated with receiving a signal from an external device.

Abstract: An exemplary hearing device includes a memory storing instructions and a processor communicatively coupled to the memory. The processor may be configured to execute the instructions to receive an input audio signal having a range of input frequencies, adaptively adjust a cut-off frequency for the input audio signal such that a value of the cut-off frequency varies between a predefined minimum cut-off frequency value and a predefined maximum cut-off frequency value as a continuous function of the input audio signal, and generate an output audio signal by mapping the range of input frequencies to a range of output frequencies determined based on the adaptively adjusted cut-off frequency.

Abstract: An exemplary hearing device is configured to receive a first signal output by a local microphone that is a part of the hearing device at a first location. The first signal is representative of a degraded version of audio content as detected by the local microphone. The audio content is provided by an audio source at a second location. The hearing device is further configured to receive a second signal from a remote microphone system located in proximity of the second location. The second signal is representative of a cleaner version of the audio content as detected by the remote microphone system. The hearing device is further configured to determine a relatedness factor between the first signal and the second signal and apply, based on the relatedness factor, a signal enhancing operation to the first signal to output an enhanced first signal.

Abstract: An exemplary hearing device is configured to receive a first signal output by a local microphone that is a part of the hearing device at a first location. The first signal is representative of a degraded version of audio content as detected by the local microphone. The audio content is provided by an audio source at a second location. The hearing device is further configured to receive a second signal from a remote microphone system located in proximity of the second location. The second signal is representative of a cleaner version of the audio content as detected by the remote microphone system. The hearing device is further configured to determine a relatedness factor between the first signal and the second signal and apply, based on the relatedness factor, a signal enhancing operation to the first signal to output an enhanced first signal.

Abstract: There is provided a hearing assistance system, comprising a transmission unit comprising a microphone arrangement for capturing audio signals from a voice of a speaker using the transmission unit and being adapted to transmit the audio signals as radio frequency signal via a wireless RF link; a left ear hearing device and a right ear hearing device, each hearing device being adapted to stimulate the user's hearing and to receive an RF signal from the transmission unit via the wireless RF link and comprising a microphone arrangement for capturing audio signals from ambient sound.

Abstract: There is provided a hearing assistance system, comprising a transmission unit comprising a microphone arrangement for capturing audio signals from a voice of a speaker using the transmission unit and being adapted to transmit the audio signals as radio frequency signal via a wireless RF link; a left ear hearing device and a right ear hearing device, each hearing device being adapted to stimulate the user's hearing and to receive an RF signal from the transmission unit via the wireless RF link and comprising a microphone arrangement for capturing audio signals from ambient sound.

Abstract: The present invention relates to polypeptides that inhibit the NF-?B signaling pathway and polynucleotides encoding the same. The present invention further provides methods for the modulation of and/or treatment of inflammatory responses, oncogenesis, viral infection; the regulation of cell proliferation and apoptosis; and regulation of B or T lymphocytes in antigenic stimulation, by administering the polypeptides of the present invention to a subject in need thereof. Finally, the present invention provides a method of identifying polypeptides that modulate oligomerization of NEMO.

Abstract: The present invention relates to nucleotide sequences encoding a modulator of NF-?B, and to the polypeptides encoded by the nucleotide sequences. In particular, the invention relates to nucleotide sequences and the polypeptides encoded thereby, wherein the polypeptides are involved in the response to NF-?B-activating stimuli, including HTLV-1 Tax, LPS, PMA and IL-1. The invention also relates to antibodies to the modulator of NF-?B, methods of detecting modulator of NF-?B using the antibodies, methods of treatment associated with NF-?B activation and to methods of identifying compounds which modulate the activity of the modulator of NF-?B.

Abstract: The present invention relates to nucleotide sequences encoding a modulator of NF-?B, and to the polypeptides encoded by the nucleotide sequences. In particular, the invention relates to nucleotide sequences and the polypeptides encoded thereby, wherein the polypeptides are involved in the response to NF-?B-activating stimuli, including HTLV-1 Tax, LPS, PMA and IL-1. The invention also relates to antibodies to the modulator of NF-?B, methods of detecting modulator of NF-?B using the antibodies, methods of treatment associated with NF-?B activation and to methods of identifying compounds which modulate the activity of the modulator of NF-?B.

Abstract: The present invention relates to polypeptides that inhibit the NF-&kgr;B signaling pathway and polynucleotides encoding the same. The present invention further provides methods for the modulation of and/or treatment of inflammatory responses, oncogenesis, viral infection; the regulation of cell proliferation and apoptosis; and regulation of B or T lymphocytes in antigenic stimulation, by administering the polypeptides of the present invention to a subject in need thereof. Finally, the present invention provides a method of identifying polypeptides that modulate oligomerization of NEMO.

Abstract: The present invention relates to nucleotide sequences encoding a modulator of NF-?B, and to the polypeptides encoded by the nucleotide sequences. In particular, the invention relates to nucleotide sequences and the polypeptides encoded thereby, wherein the polypeptides are involved in the response to NF-?B-activating stimuli, including HTLV-1 Tax, LPS, PMA and IL-1. The invention also relates to antibodies to the modulator of NF-?B, methods of detecting modulator of NF-?B using the antibodies, methods of treatment associated with NF-?B activation and to methods of identifying compounds which modulate the activity of the modulator of NF-?B.

Abstract: The present invention relates to polypeptides that inhibit the NF-&kgr; B signaling pathway and polynucleotides encoding the same. The present invention further provides methods for the modulation of and/or treatment of inflammatory responses, oncogenesis, viral infection; the regulation of cell proliferation and apoptosis; and regulation of B or T lymphocytes in antigenic stimulation, by administering the polypeptides of the present invention to a subject in need thereof. Finally, the present invention provides a method of identifying polypeptides that modulate oligomerization of NEMO.

Abstract: The present invention relates to polypeptides that inhibit the NF-?B signaling pathway and polynucleotides encoding the same. The present invention further provides methods for the modulation of and/or treatment of inflammatory responses, oncogenesis, viral infection; the regulation of cell proliferation and apoptosis; and regulation of B or T lymphocytes in antigenic stimulation, by administering the polypeptides of the present invention to a subject in need thereof. Finally, the present invention provides a method of identifying polypeptides that modulate oligomerization of NEMO.

Abstract: The present invention relates to polypeptides that inhibit the NF-?B signaling pathway and polynucleotides encoding the same. The present invention further provides methods for the modulation of and/or treatment of inflammatory responses, oncogenesis, viral infection; the regulation of cell proliferation and apoptosis; and regulation of B or T lymphocytes in antigenic stimulation, by administering the polypeptides of the present invention to a subject in need thereof. Finally, the present invention provides a method of identifying polypeptides that modulate oligomerization of NEMO.

Abstract: The present invention relates to polypeptides that inhibit the NF-?B signaling pathway and polynucleotides encoding the same. The present invention further provides methods for the modulation of and/or treatment of inflammatory responses, oncogenesis, viral infection; the regulation of cell proliferation and apoptosis; and regulation of B or T lymphocytes in antigenic stimulation, by administering the polypeptides of the present invention to a subject in need thereof. Finally, the present invention provides a method of identifying polypeptides that modulate oligomerization of NEMO.

Abstract: The present invention relates to nucleotide sequences encoding a modulator of NF-&kgr;B, and to the polypeptides encoded by the nucleotide sequences. In particular, the invention relates to nucleotide sequences and the polypeptides encoded thereby, wherein the polypeptides are involved in the response to NF-&kgr;B-activating stimuli, including HTLV-1 Tax, LPS, PMA and IL-1. The invention also relates to antibodies to the modulator of NF-&kgr;B, methods of detecting modulator of NF-&kgr;B using the antibodies, methods of treatment associated with NF-&kgr;B activation and to methods of identifying compounds which modulate the activity of the modulator of NF-&kgr;B.